Evolving US Pricing Policy Part 2
The US Pricing Shift: Implications for Global Launch and Value Strategy
The US pricing environment is changing. The implications are still unfolding...
Medicare Price Negotiations have begun, and the first wave of Maximum Fair Prices have taken effect. What this means for US net revenue, global reference pricing, and launch sequencing is still evolving.
For global teams, the question is not whether every assumption will change, but whether current strategies are resilient enough if they do.
Authored by Associate Director, Louisa Oliver Byrne, this article explores how emerging US pricing reforms could influence global launch planning, sequencing decisions, and long term value strategy and how leadership teams can prepare without overreacting.
Why download?
Stress-test your global revenue assumptions against emerging US pricing pressure
Understand possible implications for international reference pricing dynamics
Revisit launch sequencing strategies under different pricing scenarios
Align cross functional teams around informed, forward looking discussion
Equip leadership with a structured way to think through uncertainty
What's inside?
An overview of the evolving US pricing landscape and negotiation rollout
Scenario based analysis of how lower US benchmarks could influence global pricing
Strategic considerations for launch sequencing and portfolio timing
Implications for evidence strategy and value communication
A structured question framework for global teams
This Resource is Essential For: Global Pricing and Market Access leaders, Launch and Lifecycle Excellence leaders, HEOR and Evidence Strategy leads, who are seeking a structured way to think through the strategic implications of the US pricing reform.
Get Your Resource
